Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products.
What Sun files
- Others51
- Important12
- Updates11
- Board Meeting10
- PPTs4
- Results2
Sun Pharma Advanced Research Company Ltd (SPARC) has announced a board meeting on June 30, 2025, to consider the financial results for the quarter and half-year ended June 30, 2025. For the year ended March 31, 2025, SPARC reported total standalone income of ₹73.56 Cr, down from ₹105.02 Cr in...
Sun Pharma Advanced Research Company has announced a board meeting to discuss the financial results for the quarter and nine months ended December 31, 2024. The integrated filing includes key financial outcomes, demonstrating the company's ongoing commitment to transparency. With no deviations in fund utilization or outstanding defaults on loans,...